SANOFI CONSUMER HEALTHCARE INDIA SHARE PRICE

Sanofi Consumer Healthcare India Limited was incorporated on May 10, 2023, as part of Sanofi`s global strategy to establish a standalone Consumer Healthcare business. This strategic move resulted in the demerger of the Consumer Healthcare business from Sanofi India Limited (SIL) into the Company through a Scheme of Arrangement, thereby creating a distinct legal entity. The Scheme of Arrangement, which was sanctioned by the National Company Law Tribunal, Mumbai (NCLT) enabled the seamless transfer and vesting of all assets, liabilities, and operations of SIL to the Company. Pursuant to the Scheme becoming effective, the Consumer Healthcare Division (CHC) business of Sanofi India Limited (SIL) got demerged into the Company as a going concern through the Scheme of Arrangement and became effective from June 1, 2024. In terms of the said Scheme, the Company allotted 23,030,622 Equity Shares to the eligible shareholders of Sanofi India Limited (SIL) upon the demerger. The demerger was strategically undertaken to facilitate independent and focused management for both businesses, enhance operational efficiency, provide greater transparency for stakeholders, and unlock shareholder value. This separation empowered each entity to implement tailored strategies aligned with its respective industry dynamics, ensuring greater agility and long-term growth. The effective date of the Scheme was June 1, 2023. As per the Scheme, eligible shareholders of SIL received one fully paid-up equity share of the Company for every share they held in SIL on June 13, 2024.

Sanofi Consumer Healthcare India share price as on 22 Jun 2025 is Rs. 5055. Over the past 6 months, the Sanofi Consumer Healthcare India share price has increased by 4.01% and in the last one year, it has increased by 3.09%. The 52-week low for Sanofi Consumer Healthcare India share price was Rs. 4211.55 and 52-week high was Rs. 5520.

Sanofi Consumer Healthcare India Limited was incorporated on May 10, 2023, as part of Sanofi`s global strategy to establish a standalone Consumer Healthcare business. This strategic move resulted in the demerger of the Consumer Healthcare business from Sanofi India Limited (SIL) into the Company through a Scheme of Arrangement, thereby creating a distinct legal entity. The Scheme of Arrangement, which was sanctioned by the National Company Law Tribunal, Mumbai (NCLT) enabled the seamless transfer and vesting of all assets, liabilities, and operations of SIL to the Company. Pursuant to the Scheme becoming effective, the Consumer Healthcare Division (CHC) business of Sanofi India Limited (SIL) got demerged into the Company as a going concern through the Scheme of Arrangement and became effective from June 1, 2024. In terms of the said Scheme, the Company allotted 23,030,622 Equity Shares to the eligible shareholders of Sanofi India Limited (SIL) upon the demerger. The demerger was strategically undertaken to facilitate independent and focused management for both businesses, enhance operational efficiency, provide greater transparency for stakeholders, and unlock shareholder value. This separation empowered each entity to implement tailored strategies aligned with its respective industry dynamics, ensuring greater agility and long-term growth. The effective date of the Scheme was June 1, 2023. As per the Scheme, eligible shareholders of SIL received one fully paid-up equity share of the Company for every share they held in SIL on June 13, 2024.

Sanofi Consumer Healthcare India share price as on 22 Jun 2025 is Rs. 5055. Over the past 6 months, the Sanofi Consumer Healthcare India share price has increased by 4.01% and in the last one year, it has increased by 3.09%. The 52-week low for Sanofi Consumer Healthcare India share price was Rs. 4211.55 and 52-week high was Rs. 5520.